Driehaus Capital Management LLC Catalent, Inc. Transaction History

Driehaus Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$38.72 - $42.52 $2.61 Million - $2.87 Million	-67,480 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$39.4 - $47.39 $691,982 - $832,310	17,563 Added 35.18%	67,480 $2.77 Million
Q4 2017 Feb 14, 2018	SELL	$37.27 - $43.02 $679,655 - $784,512	-18,236 Reduced 26.76%	49,917 $2.05 Million
Q3 2017 Nov 14, 2017	BUY	$33.75 - $41.67 $2.3 Million - $2.84 Million	68,153	68,153 $2.72 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.